|
1
|
Burton C, McKinstry B, Szentagotai Tătar
A, SerranoBlanco A, Pagliari C and Wolters M: Activity monitoring
in patients with depression: A systematic review. Affect Disord.
145:21–28. 2013. View Article : Google Scholar
|
|
2
|
Wu F, Kong LT and Tang YQ: Effects of
fluoxetine and tianeptine on protein kinase C expression in
hippocampus in rat models of chronic stress. Zhong Guo Quan Ke Yi
Xue. 15:1375–1377. 2012.(In Chinese).
|
|
3
|
Vorhees CV, Morford LR, Graham DL, Skelton
MR and Williams MT: Effects of periadolescent fluoxetine and
paroxetine on elevated plus-maze, acoustic startle, and swimming
immobility in rats while on and off-drug. Behav Brain Funct.
7:412011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie Z, Li HF and Liu JM: Study on the
expression of central protein kinase C and adenylate cyclase in
depression rats with and without antidepressant treatment. Zhong
Guo Shen Jing Jing Shen Ji Bing Za Zhi. 36:225–228. 2010.(In
Chinese).
|
|
5
|
Hahn CG, Umapathy, Wang HY, et al: Lithium
and valproic acid treatments reduce PKC activation and receptor-G
protein coupling in platelets of bipolar manic patients. J
Psychiatr Res. 39:355–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu J and Liu J: Change of cyclic adenosine
monophosphate concentration and PKC expression in behavioral
deficit-induced depression rat brain. Zhong Hua Jing Shen Ke Za
Zhi. 35:173–176. 2002.(In Chinese).
|
|
7
|
Nestler EJ, Barrot M, DiLeone RJ, et al:
Neurobiology of depression. Neuron. 34:13–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wierda KD, Toonen RF, de Wit H, Brussaard
AB and Verhage M: Interdependence of PKC-dependent and
PKC-independent pathways for presynaptic plasticity. Neuron.
54:275–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Purgato M, Papola D, Gastaldon C, Trespidi
C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A and
Barbui C: Paroxetine versus other anti-depressive agents for
depression. Cochrane Database Syst Rev. 4:CD0065312014.PubMed/NCBI
|
|
10
|
Bai YF, Wang Y and Liu XD: Changes of
glial fibrillary acidic protein and c-fos levels in rat models of
chronic stress depression. Zhong Guo Zhi Ye Yi Xue. 37:458–461.
2010.(In Chinese).
|
|
11
|
Keck ME, Sartori SB, Welt T, Müller MB,
Ohl F, Holsboer F, Landgraf R and Singewald N: Differences in
serotonergic neurotransmission between rats displaying high or low
anxiety/depression-like behaviour: Effects of chronic paroxetine
treatment. J Neurochem. 92:1170–1179. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tyeryar KR, Vongtau HO and Undieh AS:
Diverse antidepressants increase CDP-diacylglycerol production and
phosphatidylinositide resynthesis in depression-relevant regions of
the rat brain. BMC Neurosci. 9:122008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang X: Effect of cAMP/PKA/CREB signaling
pathway and regulatory proteins PDE-4 and ERK on learning and
memory function. Yi Xue Zong Shu. 17:2241–2243. 2011.(In
Chinese).
|
|
14
|
Zheng L and Wang YM: Changes in serum
neurotrophic factor 3 after paroxetine treatment in depression. Gui
Yang Yi Xue Yuan Xue Bao. 38:347–350. 2013.(In Chinese).
|
|
15
|
Hu Y, Yin WG, Lin R and Li W: Comparison
of brain-derived neurotrophic factor levels in hippocampus and
serum in two rat models of depression. Zhong Guo Lao Nian Xue Za
Zhi. 29:2188–2190. 2009.(In Chinese).
|
|
16
|
Wei KL, Cheng YM, Sang WH, et al:
Comparative study of duloxetine and paroxetine in treating
depression with different symptoms. Zhongguo Lin Chuang Yao Li Xue
Za Zhi. 27:252–254. 2011.(In Chinese).
|
|
17
|
Yang M, Wen SY and Wu MC: Improvement in
negative emotion and inflammatory factor levels in chronic heart
failure patients after paroxetine treatment. Zhong Guo Yao Fang.
24:3433–3435. 2013.(In Chinese).
|
|
18
|
Fei HZ, Wang H, Hu XY, et al: Improvement
in oxidative stress, HPA axis function, and hippocampal
brain-derived neurotrophic factor expression after paroxetine
treatment. Zhong Guo Lin Chuang Yao Li Xue Za Zhi. 17:1137–1142.
2012.(In Chinese).
|
|
19
|
Meng X: Effects of paroxetine combined
with mental intervention on post-stroke depression. Pract Prev Med.
18:491–493. 2011.
|
|
20
|
Ni GH, Shao B and Fan H: Effects of
restraint stress and paroxetine in post-stroke rats. Chongqing Yi
Xue Za Zhi. 391033–1035. (1038)2010.(In Chinese).
|
|
21
|
Abrial E, Lucas G, Scarna H, Haddjeri N
and Lambás-Señas L: A role for the PKC signaling system in the
pathophysiology and treatment of mood disorders: Involvement of a
functional imbalance? Mol Neurobiol. 44:407–419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Réus GZ, Stringari RB, Ribeiro KF, Ferraro
AK, Vitto MF, Cesconetto P, Souza CT and Quevedo J: Ketamine plus
imipramine treatment induces antidepressant-like behavior and
increases CREB and BDNF protein levels and PKA and PKC
phosphorylation in rat brain. Behav Brain Res. 221:166–171. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding G, Yu G, Wu Y, et al: Effects of
Jiawei Xiaoyao decoction on cAMP, PKA, and PKC levels in
hippocampus of depression rats. Zhong Guo Shi Yan Fang Ji Xue Za
Zhi. 18:162–164. 2012.(In Chinese).
|
|
24
|
Li Z: Role of brain-derived neurotrophic
factor in depression pathogenesis. Shanghai Jiao Tong Da Xue Xue
Bao (Yi Xue Ban). 30:651–655. 2010.(In Chinese).
|
|
25
|
Liu X and Xu J: Changes of protein kinase
CβII expression in subcellular fractions from stress-induced
depression rat brain. Zhong Guo Xing Wei Yi Xue Ke Xue Za Zhi.
14:678–680. 2005.(In Chinese).
|
|
26
|
Zheng H, Ma G and Fu X: Effects of
paroxetine on hippocampus-dependent learning and memory and
ERK-CREB signaling pathway in rat models of depression. Zhong Guo
Yao Xue Za Zhi. 43:1234–1238. 2008.(In Chinese).
|
